Bartosz Puła

14PUBLICATIONS
61CO-AUTHORS
Respiratory diseasesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical bacteriologyChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 10, 2026
Efficacy and tolerability of venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukemia - real-world analysis of Polish adult leukemia study group.

|Feb 18, 2026
Daratumumab or active observation for asymptomatic biochemical relapse in patients with multiple myeloma.

Krzysztof Jamroziak, Dominik Dytfeld, Tadeusz Kubicki

|Nov 27, 2025
The Development of Novel Therapies for Chronic Lymphocytic Leukaemia in the Era of Targeted Drugs.

Tadeusz Robak, Elżbieta Iskierka-Jażdżewska, Anna Puła

|Aug 01, 2025
Venetoclax and obinutuzumab in first-line treatment of unfit patients with CLL - real-life data analysis of the Polish Adult leukemia group.

Klaudia Zielonka, Błażej Izdebski, Joanna Drozd-Sokołowska

|Nov 27, 2024
Measurable Residual Disease in Hematological Cancers.

Krzysztof Jamroziak, Bartosz Puła

|May 25, 2024
A Review of Resistance Mechanisms to Bruton's Kinase Inhibitors in Chronic Lymphocytic Leukemia.

Kamil Wiśniewski, Bartosz Puła

Pageof 3

Frequent Collaborators

4 joint publications

Krzysztof Jamroziak

4 joint publications

Tadeusz Robak

4 joint publications

Elżbieta Iskierka-Jażdżewska

3 joint publications

Paweł Robak